Preclinical Neurobiology Services Booklet
Read Flipbook
Read Flipbook
Watch this webinar to learn how JAX is leveraging biomarkers—measurable indicators of disease presence, progression, and treatment response—in ALS mouse models.
Watch Video
Watch this webinar to learn how JAX leverages validated models of neurodegenerative and neurodevelopmental disease to evaluate biodistribution, efficacy, and target engagement.
Watch Video
In this episode, we delve into a publication that established a novel humanized mouse model of graft-versus-leukemia that better recapitulates the characteristics of AML relapse seen in patients.
Watch Video
Read Flipbook
Read Flipbook
During this webinar, we discuss best practices for model selection, study design, and experimental reproducibility.
Watch Video
Join the JAX In Vivo Services team as they share insights from extensive neurobiology drug discovery studies conducted for both academic and commercial clients.
Watch Video
Read Flipbook
During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.
Watch Video
Learn about the complexity of rare disease and the unique difficulty it presents to patients and families by exploring the patient journey—from diagnosis to research to drug development.
Learn More
Read Flipbook
Learn how mouse models help researchers disentangle the complexity of rare disease and help drive preclinical drug development.
Learn More
February 7, 2023 - In this episode, we discuss the importance of studying rare diseases and the critical preclinical steps leading to diagnosis and treatment development.
Watch Video
Read Flipbook
Learn how to overcome the challenges to develop gene therapies, specifically for neurodevelopmental and neurodegenerative diseases.
Watch Video
The Jackson Laboratory is the exclusive service provider for robust, reliable, reproducible gene therapy, efficacy, and safety studies in the C9orf72 mouse model, the most common form of familial ALS.
Read Flipbook
Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.
Watch Video
Watch this webinar to review phenotypic characteristics, considerations for selecting therapeutically relevant ALS models, and more!
Watch Video
Read Flipbook
Loading More...